Exercise Training and Metabolic Syndrome
- Conditions
- Metabolic Syndrome
- Interventions
- Behavioral: Aerobic interval training
- Registration Number
- NCT03036332
- Lead Sponsor
- Universidade Estadual Paulista JĂșlio de Mesquita Filho
- Brief Summary
The present study aimed to determine the effects of 16 weeks of aerobic interval training on quality of life and a set of clinical biomarkers.
- Detailed Description
Besides the traditional metabolic syndrome risk factors (dyslipidemia, raised blood pressure, central obesity and dysglycemia) subclinical disorders related to chronic inflammation and cell damage have been reported on metabolic syndrome. Therefore, regarding the systemic feature of metabolic syndrome, we investigated an new approach of aerobic interval training on several clinical biomarkers widely used. Such training used differs from current aerobic protocols in order to attenuate metabolic and musculoskeletal overload on untrained and unhealthy subjects.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 53
- Having metabolic syndrome according to international diabetes foundations definition (IDF).
- Age between 35 - 60 years and untrained subjects.
- Musculotendinous or osteoarticular injuries in the lower limbs and/or spine
- Chronic pulmonary diseases
- Neurological disorders
- Kidney failure
- High-risk cardiovascular diseases (Unstable angina pectoris, Uncompensated heart failure, complex ventricular arrhythmias or myocardial infarction during the last month).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description intervention Aerobic interval training Aerobic interval training
- Primary Outcome Measures
Name Time Method Pro-inflammatory marker 16 weeks Serum levels of C-reactive protein
- Secondary Outcome Measures
Name Time Method Quality of life 16 weeks The Medical Outcomes Study-Short Form 36 (SF-36)
A set of clinical biomarkers 16 weeks Serum levels lof Homocysteine; Creatinine, Creatine kinase (ck); creatine kinase MB (ck-mb); Troponin t; aspartate aminotransferase; alanine aminotransferase; and complete blood count.